Alpha Stack

Alpha Stack operates as a specialized pre-seed technology incubator and investor in Prague, focused on software-defined healthcare and AI solutions at the earliest stages of company formation. The model sits between a traditional venture fund and an incubator, with the firm willing to engage with founders before formal incorporation when the technical thesis is compelling. Digital health is the primary healthcare focus.

The thesis is anchored in the conviction that pre-seed is the stage where the most meaningful technical and product decisions are made, and where capital and operational support produce the most leverage. Alpha Stack engages with healthcare-focused founders who are building software-first products, with an emphasis on companies where machine learning or AI is core rather than incidental to the value proposition. The portfolio leans toward companies that can validate their technical hypothesis with a small initial check and a tight operating cadence rather than companies that require large amounts of capital to reach a meaningful milestone.

Alpha Stack writes checks generally below $250k, which positions it as a true first money in rather than a seed lead. The pre-seed and seed stage focus means founders engaging with Alpha Stack are typically still defining the initial product, the first hires, and the early go-to-market hypothesis. Geographically, the firm is most active in the Czech Republic and the broader CEE region, with selective work outside that footprint when there is a strong technical match. The check size is calibrated to extend a founder’s runway long enough to validate a thesis and bring in a larger seed round, rather than to fund a company through to commercial scale on its own.

The team is small and operates with an incubator-style cadence rather than the more transactional rhythm of a traditional venture fund. Founders should expect ongoing operational engagement rather than quarterly board meetings, particularly in the first year. That model fits some founders well and frustrates others, and the alignment is worth establishing during diligence.

In working with companies, Alpha Stack is most useful for early product strategy, technical architecture decisions, and bridging founders into the next round of capital. The firm has working relationships with seed leads in Prague, Warsaw, Berlin, and London that can lead a follow-on round when traction supports it. For healthcare founders, the value is most pronounced for those building software-defined products who benefit from rapid iteration with an engaged investor, rather than those building regulated medical devices or biotech that require longer pre-revenue arcs. Alpha Stack is less suited to founders who want a passive financial investor or to companies that need significant capital up front to reach their first meaningful milestone. Founders considering Alpha Stack should plan for an active early relationship, a small initial check designed to be followed by a larger institutional round, and a focus on getting the technical and product foundations right before scaling.